Fingerprint
Dive into the research topics of 'Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically